ArticleInflammation2019

Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis.

Noha F Hassan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.